Joshua Richter, MD, Assistant Professor, Division of Hematology and Medical Oncology @TischCancer tells us about the design and outcomes of the Phase 3 CANDOR study in relapsed/refractory multiple myeloma.
CANDOR Study in MM @TischCancer
Joshua Richter, MD, Assistant Professor, Division of Hematology and Medical Oncology @TischCancer tells us about the design and outcomes of the Phase 3 CANDOR study in relapsed/refractory multiple myeloma.